Arlesey, United Kingdom

Darko Sutina

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Darko Sutina. Retrieved from https://idiyas.com/inventor/darko-sutina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Darko Sutina

Introduction: Darko Sutina is a notable inventor based in Arlesey, Great Britain. With a focus on the development of innovative chemical compounds, he has made significant contributions to the field of pharmaceuticals through his patent work.

Latest Patents: Darko holds one patent for a series of indole derivatives. These compounds are characterized by the formula (I) ##STR1##, where R₁ can represent either hydrogen or a linear alkyl group consisting of 1 to 6 carbon atoms. This innovation is an essential step in the exploration of new therapeutic agents.

Career Highlights: Darko Sutina is associated with Glaxo Group Limited, a renowned company in the pharmaceutical industry. His work at Glaxo has allowed him to engage in pioneering research, driving forward the potential applications of his inventions in healthcare.

Collaborations: Throughout his career, Darko has collaborated with esteemed colleagues, including Alexander W. Oxford and Martin Richard Owen. Their teamwork has further enriched the innovation culture at Glaxo Group Limited, leading to advancements in medical science.

Conclusion: Darko Sutina represents the spirit of innovation in the pharmaceutical sector. His patent on indole derivatives not only showcases his inventive prowess but also highlights the collaborative efforts that are vital in the realm of research and development in pharmaceuticals. As he continues his work at Glaxo, more advancements can be anticipated from his contributions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…